scispace - formally typeset
A

Arimantas Tamašauskas

Researcher at Lithuanian University of Health Sciences

Publications -  95
Citations -  1317

Arimantas Tamašauskas is an academic researcher from Lithuanian University of Health Sciences. The author has contributed to research in topics: Glioma & Glasgow Outcome Scale. The author has an hindex of 19, co-authored 88 publications receiving 1021 citations. Previous affiliations of Arimantas Tamašauskas include Hospital of Lithuanian University of Health Sciences Kaunas Clinics.

Papers
More filters
Journal ArticleDOI

Predictors of health-related quality of life in neurosurgical brain tumor patients: focus on patient-centered perspective.

TL;DR: Consciousness and emotional stability should be considered important personality-related determinants of HRQoL in BT patients, as they are important predictors of psychological distress, functional disability, and cognitive impairment.
Journal ArticleDOI

Management of cerebrospinal fluid leak after surgical removal of pituitary adenomas.

TL;DR: The technique of covering the sella membrane and dural defects with Surgicel and TachoSil in the presence of intra- and postoperative cerebrospinal fluid leakage appeared to be the most reliable one, as no postoperative CSF leakage applying this technique has been observed.
Journal ArticleDOI

Brain lesions manifesting as psychiatric disorders: eight cases.

TL;DR: This study presents eight cases of patients with brain lesions who, for a significant period of time, were diagnosed and treated for psychiatric disorders and show that brain tumors can be neurologically silent for a sufficient period ofTime and manifest as psychiatric disorders.
Journal ArticleDOI

MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma

TL;DR: High methylation frequency of tested genes shows heterogeneity of glioblastoma epigenome and the importance of MGMT, GATA6 and CASP8 genes methylation in gliOBlastoma patient outcome.
Journal ArticleDOI

Low triiodothyronine syndrome as a predictor of poor outcomes in patients undergoing brain tumor surgery: a pilot study: clinical article.

TL;DR: Low T3 syndrome is a strong independent predictor of unfavorable clinical outcomes and depressive symptoms, and its diagnosis and preoperative management should be considered in patients undergoing neurosurgery for the treatment of brain tumors.